NR-SAFE: A Randomized, Double-Blind Safety Trial of High Dose Nicotinamide Riboside in Parkinson’s Clinical, Neurological HealthANAD StaffNovember 28, 2023Parkinson's Disease
Nicotinamide Riboside Supplementation is Not Associated with Altered Methylation Homeostasis in Parkinson’s Disease Clinical, Neurological Health, MethylationANAD StaffMarch 17, 2023Neurological Health, Parkinson's Disease, Methylation
The NADPARK Study: A Randomized Phase I Trial of Nicotinamide Riboside Supplementation in Parkinson’s Disease Clinical, Neurological HealthANAD StaffMarch 1, 2022Parkinson's Disease, Neurological Health
